About Contact Us Careers

Hepatitis B Tests Market Size & Share, by Type (Cassettes/Cards Kit, Strips Kit); Application (Hospitals, Clinics, Diagnostic Centers, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 3971
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Hepatitis B Tests Market size was valued at USD 1.41 billion in 2024 and is expected to reach USD 2.93 billion by 2037, registering around 5.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of hepatitis B tests is assessed at USD 1.48 billion.

The growth of the market can be attributed to the growing prevalence of hepatitis B, and increasing awareness levels among patients associated with early detection of the disease. According to the World Health Organization, in 2019, 296 million in the world were living with chronic hepatitis B infection, with 1.5 million new infections every year. That same year, hepatitis B resulted in the deaths of 820,000 people globally. Along with these, rise in technological advancements in molecular diagnostics, and upsurge in blood transfusion and donations in patients with hepatitis are also expected to drive market growth significantly in the forthcoming years. Furthermore, rapidly growing biotechnology and biopharmaceutical industries around the world is projected to offer profitable opportunities to the market in the near future.

HBsAg-Testing-Market
Discover Market Trends & Growth Opportunities: Request Free Sample PDF

Growth Drivers

  • Growing Prevalence of Hepatitis B
  • Increasing Awareness Among People About Early Detection of the Disease

Challenges

  • Lack of Awareness Regarding Hepatitis B Tests in Lower Economic Regions

Hepatitis B Tests Market: Key Insights

Report Attribute Details

Base Year

2024

Forecast Year

2025-2037

CAGR

5.8%

Base Year Market Size (2024)

USD 1.41 billion

Forecast Year Market Size (2037)

USD 2.93 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Access Detailed Forecasts & Data-Driven Insights: Request Free Sample PDF

Hepatitis B Tests Segmentation

The market is segmented by application into hospitals, clinics, diagnostic centers, home care, and others, out of which, the hospitals segment is anticipated to hold the largest share in the global Hepatitis B Tests market. This can be accounted to the high preference of people to get treatment from highly trained medical professionals, and presence of large patient pool in a hospital facility. Additionally, on the basis of type, the strips kit segment is predicted to grab the largest share during the forecast period owing to the high affordability, and ease of convenience for testing provided by this type of testing kits. Apart from these, tests conducted by strips kit offers results in a short span of time, which is also assessed to boost the growth of the market segment in the future.

Our in-depth analysis of the global Hepatitis B Tests market includes the following segments:

           By Type
  • Cassettes/Cards Kit
  • Strips Kit

           By Application
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Home Care
  • Others
Vishnu Nair
Vishnu Nair
Head - Global Business Development

Customize this report to your requirements — connect with our consultant for personalized insights and options.

Hepatitis B Tests Industry - Regional Synopsis

 Asia Pacific industry is anticipated to account for largest revenue share by 2037, backed by large number of patients, and growing occurrence of hepatitis in the region, backed by large number of patients, and growing occurrence of hepatitis in the region. Moreover, the market in North America is expected to grab the largest share during the forecast period, which can be credited largely to the high availability of advanced diagnostic tools in the region. In addition, increasing number of government initiatives to raise awareness about hepatitis, and high healthcare expenditure are also projected to drive the market growth in the region in the coming years. As per the Centers for Medicare & Medicaid Services (CMS), the healthcare spending in the United States grew by 9.7% in 2020, reaching a value of USD 4.1 trillion. As a share of the nation’s Gross Domestic Product (GDP), the health spending accounted for about 19.7%.

Hepatitis B Tests Market
Get Strategic Analysis by Region Now: Request Free Sample PDF

Companies Dominating the Hepatitis B Tests Landscape

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • F. Hoffman-La Roche AG
    • Siemens AG
    • Bio-Rad Laboratories, Inc.
    • Danaher Corporation
    • bioMérieux SA
    • DiaSorin S.P.A.
    • MedMira Inc.
    • Fujirebio US, Inc.
    • Grifols, S.A."

Recent Developments

  • In 2023, GSK is actively researching ways to enhance the effectiveness of treatment for chronic hepatitis B by combining Bepirovirsen with other therapies, including pegylated interferon, vaccines, and inhibitors of the PAPD5 and PAPD7 enzymes.
     
  • March 2021- Roche and Dicerna started Phase II trial of GalXC RNAi candidate, RG6346, for treating chronic hepatitis B virus (HBV) infection.
  • Report ID: 3971
  • Published Date: Dec 26, 2024
  • Report Format: PDF, PPT
  • Get detailed insights on specific segments/region
  • Inquire about report customization for your industry
  • Learn about our special pricing for startups
  • Request a demo of the report’s key findings
  • Understand the report’s forecasting methodology
  • Inquire about post-purchase support and updates
  • Ask About Company-Level Intelligence Additions

Have specific data needs or budget constraints?

customer-service Inquiry Before Buying

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of hepatitis B tests is assessed at USD 1.48 billion.

Hepatitis B Tests Market size was valued at USD 1.41 billion in 2024 and is expected to reach USD 2.93 billion by 2037, registering around 5.8% CAGR during the forecast period i.e., between 2025-2037.

Asia Pacific industry is anticipated to account for largest revenue share by 2037, backed by large number of patients, and growing occurrence of hepatitis in the region.

The major players in the market are Abbott Laboratories, F. Hoffman-La Roche AG, Siemens AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and others.

HBsAg Testing Market Report Scope

GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

Connect with our Expert

Radhika Pawar
Radhika Pawar
Senior Research Analyst
Get a Free Sample

See how top U.S. companies are managing market uncertainty — get your free sample with trends, challenges, macroeconomic factors, charts, forecasts, and more.

Inquiry Before Buying Request Free Sample PDF

Copyright @ 2025 Research Nester. All Rights Reserved.

footer-bottom-logos